留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

群体药动学应用于个体化给药的研究进展

林艳

downloadPDF
文章导航 > 药学实践与服务  > 2015 >  33(4): 293-297,346
林艳. 群体药动学应用于个体化给药的研究进展[J]. 药学实践与服务, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
引用本文: 林艳. 群体药动学应用于个体化给药的研究进展[J]. 药学实践与服务, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
shu
LIN Yan. Research progress of population pharmacokinetics applying to individualized medication[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
Citation: LIN Yan. Research progress of population pharmacokinetics applying to individualized medication[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
shu

群体药动学应用于个体化给药的研究进展

doi: 10.3969/j.issn.1006-0111.2015.04.002

  • 同济大学附属杨浦医院药剂科, 上海 200433

Research progress of population pharmacokinetics applying to individualized medication

  • Department of Pharmacy, Yangpu Hospital affiliated to Tongji University, Shanghai 200433, China

  • 摘要: 群体药动学运用经典的药动学原理结合统计学方法,以稀疏数据预测患者血药浓度,可达到监测药物体内过程和指导临床个性化给药的目的。查阅近年来的相关文献,结合实例综述群体药动学应用于治疗窗窄的药物、个体差异大的药物、联合用药、特殊人群用药等方面的最新进展,为其深入研究和指导临床用药提供参考。
    Abstract: Combining the classic pharmacokinetic principles and statistical methods, population pharmacokinetics (PPK) can predict individual pharmacokinetic parameters accurately with sparse data in patients, which may be used for monitoring drug concentration in patients and realizing individual dose regimen. In this article, we review the recent application of PPK in drugs with narrow therapeutic windows or great individual differences, combining medication, medication in special populations and so on, providing useful information for further investigation of PPK and its application in clinical medication.
  • [1] 倪天庆, 胡思源, 司端运, 等. 中药儿童群体药动学试验设计要点[J]. 中草药, 2013, 44(021): 3089-3091.
    [2] 张 弨, 翟所迪. 群体药动学在治序药物监测中的应用[J]. 临床药物治疗杂志, 2006, 4(1): 45-50.
    [3] 蒋新国.生物药剂学与药物动力学[M]. 北京: 高等教育出版社, 2009: 538-540.
    [4] Tatarinova T, Neely M, Bartroff J, et al.Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian[J].J Pharmacokinet Pharmacodyn, 2013, 40(2): 189-199.
    [5] Wakefield J, Walker S. Bayesian nonparametric population models: formulation and comparison with likelihood approaches[J].J Pharmacokinet Biopharm, 1997, 25(2): 235-253.
    [6] Rosner GL, Muller P. Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models[J].J Pharmacokinet Biopharm, 1997, 25(2): 209-233.
    [7] 林翠鸿, 王长连, 柯 蒙. 群体药动学及其在个体化给药中的应用[J].中国临床药学杂志, 2005,14(01): 58-60.
    [8] Schaeftlein A, Minichmayr IK, Kloft C. Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data[J].Eur J Pharm Sci, 2014,57:68-73.
    [9] Jelliffe RW. Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy[J].Ther Drug Monit, 2012, 34(4): 368-371.
    [10] 胡 敏, 张静华, 孙 鹤, 等. 群体药动学原理及NONMEM法数据分析[J].药学服务与研究, 2002,2(4): 227-230.
    [11] Sherwin CM, Kiang TK, Spigarelli MG, et al. Fundamentals of population pharmacokinetic modelling: validation methods[J].Clin Pharmacokinet, 2012, 51(9): 573-590.
    [12] Krauss M, Burghaus R, Lippert JOR, et al. Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification[J].In Silico Pharmacology, 2013, 1(1): 1-11.
    [13] Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation[J].Clin Pharmacokinet, 2004, 43(10): 623-653.
    [14] Golubovic B, Vucicevic K, Radivojevic D, et al. Total plasma protein effect on tacrolimus elimination in kidney transplant patients—population pharmacokinetic approach[J].Eur J Pharm Sci, 2013, 52: 34-40.
    [15] Seng KY, Hee KH, Soon GH, et al. CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients[J].J Clin Pharmacol, 2014, 54(2):215-224.
    [16] Yamamoto M, Kuzuya T, Baba H, et al. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type[J].J Clin Pharm Ther, 2009, 34(4): 473-483.
    [17] 翁芳娟. 万古霉素的群体药动学研究[J].海峡药学, 2013,25(7): 207-209.
    [18] N PP, D BBF. The epilepsy prescriber's guide to antiepileptic drugs[M].Oxford: Cambridge University Press, 2010.
    [19] Jovanovic M, Sokic D, Grabnar I, et al. Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling[J].Eur J Pharm Sci, 2013, 50(3-4): 282-289.
    [20] Marsot A, Boulamery A, Bruguerolle B, et al. Population pharmacokinetic analysis during the first 2 years of life: an overview[J].Clin Pharmacokinet, 2012, 51(12): 787-798.
    [21] Udy AA, Covajes C, Taccone FS, et al. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?[J].Int J Antimicrob Agents, 2013, 41(6): 564-568.
    [22] Conil JM, Georges B, Fourcade O, et al. Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration[J].Int J Clin Pharmacol Ther, 2007, 45(3): 133-142.
    [23] Conil JM, Georges B, Ravat F, et al. Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations[J].Clin Ther, 2013, 35(10): 1603-1612.
    [24] 柳晓泉, 陈渊成, 郝 琨, 等. 药动学一药效学结合模型的研究进展及在新药研发中的应用[J].中国药科大学学报, 2007, 38(6): 481-488.
    [25] 王 清, 朱萱萱, 周 杰, 等. 参麦注射液在心肌缺血患者体内的群体药动学研究[J].中华中医药学刊, 2013,31(12): 2702-2705.
    [26] Levy GA. C2 monitoring strategy for optimising cyclosporin immunosuppression from the neoral formulation[J].Biodrugs, 2001, 15(5): 279-290.
    [27] Yoshida K, Kimura T, Hamada Y, et al. Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from sandimmune to neoral in stable renal transplant patients[J].Transplant P, 2001, 33(7): 3146-3147.
    [28] Yue CS, Huynh HH, Raymond C, et al. Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteers[J].J Pharm Pharm Sci, 2013, 16(1): 89-98.
    [29] Lal R, Sukbuntherng J, Luo W, et al. Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil[J].J Clin Pharmacol, 2013, 53(1): 29-40.
  • [1] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202303023
    [2] 王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉.  全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
    [3] 丁千雪, 尚圣兰, 余梦辰, 余爱荣.  机器学习在肾病综合征患者他克莫司个体化用药中的应用 . 药学实践与服务, 2024, 42(6): 227-230, 243. doi: 10.12206/j.issn.2097-2024.202310007
    [4] 陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠.  UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404082
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3841
  • HTML全文浏览量:  408
  • PDF下载量:  867
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-07-18
  • 修回日期:  2015-03-14

群体药动学应用于个体化给药的研究进展

doi: 10.3969/j.issn.1006-0111.2015.04.002
  • 同济大学附属杨浦医院药剂科, 上海 200433
  • 收稿日期: 2014-07-18
  • 修回日期: 2015-03-14

摘要: 群体药动学运用经典的药动学原理结合统计学方法,以稀疏数据预测患者血药浓度,可达到监测药物体内过程和指导临床个性化给药的目的。查阅近年来的相关文献,结合实例综述群体药动学应用于治疗窗窄的药物、个体差异大的药物、联合用药、特殊人群用药等方面的最新进展,为其深入研究和指导临床用药提供参考。

English Abstract

林艳. 群体药动学应用于个体化给药的研究进展[J]. 药学实践与服务, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
引用本文: 林艳. 群体药动学应用于个体化给药的研究进展[J]. 药学实践与服务, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
shu
LIN Yan. Research progress of population pharmacokinetics applying to individualized medication[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
Citation: LIN Yan. Research progress of population pharmacokinetics applying to individualized medication[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 293-297,346. doi: 10.3969/j.issn.1006-0111.2015.04.002
shu

    全文HTML

参考文献 (29)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计